You are here: Home » PTI Stories » National » News
Business Standard

Piramal Critical Care launches Morphine Sulfate injection in US

Press Trust of India  |  New Delhi 

Critical Care Monday said it has launched in the US Sulfate injection with trademark used for treatment of intractable chronic

The injection has been launched in 10 mg/ml and 25 mg/ml concentrations, Critical Care said in a statement.

"We are pleased to support intrathecal therapy for management with approval and our launch of Mitigo," Critical Care said.

has established itself as the with Gablofen which it has successfully integrated post acquisition from Mallinckrodt, he added.

It is a business division of and present in anesthesia, management, and intrathecal therapy segments.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, March 11 2019. 20:55 IST
RECOMMENDED FOR YOU